Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Academics Get to Test Flow Chemistry System for Free

Published: Monday, October 22, 2007
Last Updated: Monday, October 22, 2007
Bookmark and Share
Syrris has announced the winners of its competition to win the use of its new FRX300 flow chemistry system.

Syrris has announced the winners of its competition to win the use of its new FRX300 flow chemistry system. Academics from around the world were asked to submit an abstract detailing the research they would carry out if they won the use of a Syrris FRX300.

From the many entrants, the three most novel proposals came from the University of Twente, The Netherlands, the University of Southampton, UK, and the University of Oregon, USA. Each winner not only has one month’s free use of the FRX300, but also delivery, training and system support for this time.

The winning papers were; “Multiphase Gas-Liquid Reaction Processes” by the Membrane Technology Group, Faculty of Science and Technology, University of Twente, “Synthetic Studies with Flow Chemistry (including macrocyclizations, heterocycle synthesis, multicomponent condensations)” by Dr A Ganesan, the University of Southampton, and “Microreactor Control of Crystal Form and Phase” by Prof. Kenneth M. Doxsee, Department of Chemistry, University of Oregon. Amongst the many other entrants, there were applications covering such broad areas as nanosynthesis, LDA enolate chemistry, azide chemistry, PAT (Process Analytical Technology), formulations, azo dye chemistry and kinetic resolutions.

Designed for both solid- and solution-phase chemistry, the modular design of the FRX means that it allows the chemist to select the set-up that suits their individual needs.

The winning chemists will have the opportunity to explore the functionality of the FRX300 system, and apply this to their particular chemistry. The FRX300 prize includes 3 pump modules, a reagents store, a reactor adaptor, a tube- and micro-reactor, a pressurization module, a Flow Liquid-Liquid Extraction (FLLEX) for compound purification and separation post reaction, and a collection module.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Syrris Invites Chemists to Join Free Flow Chemistry Workshop in the US
Syrris is hosting a free flow chemistry workshop in Cambridge, Massachusetts, USA, on the 9th of May 2013.
Monday, April 22, 2013
Syrris Acclaimed for Latin American Presence
Extensive progress acknowledged following the opening of the Brazilian subsidiary.
Saturday, October 09, 2010
Syrris Announces Outstanding Success Following Expansion of Worldwide Operations
The Company has experienced strong 2010 start by opening its Brazilian subsidiary and new product launches.
Friday, July 16, 2010
Syrris to Host Technical Seminars in India for R&D Chemists
Applications-focused seminars to explore calorimetry, sonocrystallization and flow chemistry solutions.
Monday, May 10, 2010
Syrris Establishes Indian Subsidiary
Company expands its sales network and service support for all customers in India.
Monday, July 27, 2009
Syrris to Further Extend its Global Outreach with new Distributors Across Europe, Asia and the Middle East
Syrris has appointed three sales and customer support personnel and six distributors to support its new modular flow chemistry and synthesis systems.
Thursday, December 06, 2007
Win a Flow Chemistry System
Syrris is providing scientists with the opportunity to win one month’s free use of one of its FRX systems, the FRX300, including delivery, training and system support.
Monday, June 18, 2007
Syrris Announce new West Coast Office
To meet the growing Customer demand, Syrris expands its US sales and customer service team with the opening of an office in La Jolla, CA, to provide support for its modular flow chemistry and synthesis products.
Thursday, March 15, 2007
Buoyant Order Book Spurs Recruitment Drive at Syrris
Syrris to double sales force for its FRX and atlas as these systems demonstrate the success of the modular approach.
Tuesday, January 30, 2007
Syrris Appointed as North American Distributor of Lara and Coflux Product Lines
Syrris will be exhibiting Lara and Coflux at the forthcoming Cambridge Healthcare Institute Process R&D Summit in Philadelphia.
Monday, October 03, 2005
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!